PharmExec Staff

Articles

Johnson & Johnson, Sanofi Top the 2017 Good Pharma Scorecard

The 2017 GPS ranking evaluates clinical trial registration, results reporting, clinical study report synopsis sharing, and journal article publication rates for new drugs approved by the Food and Drug Administration in 2014 that were sponsored by large drug companies.

IMS and Quintiles Announce Merger

Combined company will have market value of around $18 billion, reports Reuters.

Pharm and Biotech Help Drive Banner Year for EMEA Deals

The pharma, medical and biotech sector accounted for the top three announced deals of the year in the EMEA region in 2014.

Slow Growth to 2020 for France's Pharma Market

The French pharmaceutical market is forecast to grow at a "tepid" CAGR of 0.7% from $46.2 billion in 2014 to $48.2 billion by 2020, according to GlobalData.

The Good, the Bad and the Ugly: CPhI Panel's Pharma Predictions for 2015

An expert CPhI Worldwide panel has identified "the good, the bad, and the ugly" in its forecast for the pharmaceutical industry for 2015.

AZ and University of Texas in Women's Cancer Collaboration

AstraZeneca (AZ) and The University of Texas MD Anderson Cancer Center (Houston, TX) have announced a multi-year, strategic research collaboration.